Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?

Lignende værker

• Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia
  af: Sun, Xiaoyan, et al.
  Udgivet: (2016)
• Imatinib-resistance without BCR/ABL Point Mutation in Chronic Myeloid Leukemia
  af: Aytan Shirinova
  Udgivet: (2024-03-01)
• BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
  af: S. I. Kutzev, et al.
  Udgivet: (2022-11-01)
• A Therapeutically Targetable Mechanism of BCR-ABL-Independent Imatinib Resistance in Chronic Myeloid Leukemia
  af: Ma, Leyuan, et al.
  Udgivet: (2014)
• Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
  af: Lan, Xiaoying, et al.
  Udgivet: (2016)